Showing results (1-10 of 82) with videos related to
Sort By:
Pageof 9
Plos One|February 3, 2023
Efficacy and safety of GSK3772847 in participants with moderate-to-severe asthma with allergic fungal airway disease: A phase IIa randomized, multicenter, double-blind, sponsor-open, comparative trialChika Akinseye, Courtney Crim, Amy Newlands, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 3, 2008
Ecologic analysis of asthma-related events and dispensing of inhaled corticosteroid- and salmeterol-containing productsRachael L DiSantostefano, Kourtney J Davis, Steve Yancey, et al.British Journal of Clinical Pharmacology|October 8, 2013
A repeat-dose thorough QT study of inhaled fluticasone furoate/vilanterol combination in healthy subjectsRodger Kempsford, Ann Allen, Kathryn Kelly, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 11, 2005
Evaluation of particle size distribution of albuterol sulfate hydrofluoroalkane administered via metered-dose inhaler with and without valved holding chambersCourtney Crim, Mark Holmes, Benjamin Lee, et al.International Journal of Chronic Obstructive Pulmonary Disease|January 6, 2016
Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular riskHenry Covelli, Bonavuth Pek, Isabelle Schenkenberger, et al.Respiratory Medicine|February 1, 2017
A randomised, phase III trial of once-daily fluticasone furoate/vilanterol 100/25 μg versus once-daily vilanterol 25 μg to evaluate the contribution on lung function of fluticasone furoate in the combination in patients with COPDThomas M Siler, Atsushi Nagai, Catherine A Scott-Wilson, et al.Allergy and Asthma Proceedings|December 21, 2006
Real-world assessment of a metered-dose inhaler with integrated dose counterRichard L Wasserman, Ketan Sheth, William R Lincourt, et al.International Journal of Chronic Obstructive Pulmonary Disease|August 9, 2020
The Summit Score Stratifies Mortality and Morbidity in Chronic Obstructive Pulmonary DiseaseBenjamin D Horne, Matthew J Hegewald, Courtney Crim, et al.Respiratory Medicine|January 29, 2013
A randomised trial of fluticasone furoate/vilanterol (50/25 μg; 100/25 μg) on lung function in COPDEdward M Kerwin, Catherine Scott-Wilson, Lisa Sanford, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 19, 2012
Development of the Shortness of Breath with Daily Activities questionnaire (SOBDA)Kellee Howard, Pamela Berry, Jennifer Petrillo, et al.Pageof 9